Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fe3O4 + FROP-1
- Development stage
- Unknown
- Modality
- Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Intratumoral
01
Overview
Fe3O4 + FROP-1 refers to a combination of magnetite nanoparticles (Fe3O4) and a functionalizing or conjugating agent, likely denoted as "FROP-1." Magnetite (Fe3O4) nanoparticles are widely used in biomedical applications due to their superparamagnetic properties, biocompatibility, and ability to be manipulated by external magnetic fields. These features make them suitable for targeted drug delivery systems, where the release of therapeutically active agents can be controlled externally using magnetic fields[2][3][7]. The addition of a functionalizing molecule such as "FROP-1" typically aims to enhance targeting specificity, improve biocompatibility, or enable conjugation with drugs or imaging agents. While the specific identity and function of "FROP-1" is not detailed in available literature, similar constructs are engineered for magnetically-tunable drug delivery systems that allow precise control over drug release profiles[1][7]. This combination is considered an advanced nanomedicine platform rather than a conventional pharmaceutical.
- Other names
- Fe3O4 + FROP-1
Beyond the preview
Go deeper on Fe3O4 + FROP-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fe3O4 + FROP-1.